Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[1,1, 1-trichloroethane-induced chronic active hepatitis].

Vincent Croquet1, Joël Fort, Frédéric Oberti

  • 1Service d'Hépato-Gastroentérologie, CHU, 49033 Angers Cedex 01.

Gastroenterologie Clinique Et Biologique
|February 21, 2003
PubMed
Summary

1,1,1-trichloroethane, a common industrial solvent, has been linked to rare cases of liver injury. This report details a unique case of chronic active hepatitis potentially caused by 1,1,1-trichloroethane exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF Cohort.

JHEP reports : innovation in hepatology·2026
Same author

[FIB-4: a simple blood test to identify patients at risk of liver complications].

La Revue du praticien·2026
Same author

Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial).

Hepatology (Baltimore, Md.)·2026
Same author

Criteria of sustainable working conditions for cancer survivors: A scoping review.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2026
Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2025
Same author

Association between return-to-work trajectories and depressive symptoms in long-term breast cancer survivors: results from the French CONSTANCES cohort.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Area of Science:

  • Toxicology
  • Hepatology
  • Environmental Health

Background:

  • 1,1,1-trichloroethane (TCA) has been extensively used as an industrial solvent since 1954.
  • Initially perceived as non-toxic, TCA has been associated with central nervous system and cardiac adverse effects.
  • Hepatotoxicity from TCA exposure is rare, with fewer than 10 reported cases.

Observation:

  • A case of liver injury possibly linked to TCA exposure is presented.
  • The patient exhibited symptoms suggestive of hepatotoxicity.
  • The pathological findings were characterized by chronic active hepatitis.

Findings:

  • The presented case demonstrates a rare instance of liver injury attributed to 1,1,1-trichloroethane.
  • The observed pathology included chronic active hepatitis, an unusual feature for TCA-induced liver damage.

Related Experiment Videos

  • This finding contrasts with the more common toxic effects seen with TCA.

    • Implications:

    • This case highlights the potential for 1,1,1-trichloroethane to cause significant liver damage, specifically chronic active hepatitis.
    • It underscores the importance of considering TCA exposure in cases of unexplained hepatitis.
    • Further investigation into the mechanisms of TCA-induced hepatotoxicity may be warranted.